Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?
- 1 May 2018
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 103 (5) , 1813-1817
Abstract
Background Unlike virtually all other cancer types, thyroid cancer is unique in that patient age is a key component in its staging. Pathologists and clinicians worldwide have accepted an age cutoff of 45 years for staging; in 2018, this advances to age 55 years in the eighth edition of the American Joint Commission on Cancer staging system. Evidence Acquisition Clinical and basic research studies, reviews, and previous editions of consensus statements regarding thyroid cancer staging were reviewed, with particular focus on the influence of age in thyroid cancer prognosis. Purpose This perspective briefly reviews the basis for this practice and challenges it as no more appropriate than for other malignancies. Evidence Synthesis The majority of findings report an association of age with thyroid cancer survival but do not support a specific age cutoff; rather, they suggest that outcome is affected by age as a continuous variable. Conceivably, other factors interact with age on a continuous basis over time, affecting prognosis. When identified, these factors could alter our current concept of the importance of an age cutoff in staging. Conclusions Among all cancers, age has an important role in only thyroid cancer staging. The consideration of age as a continuous variable and the search for age-associated prognostic variables could elucidate a more accurate staging system.Keywords
This publication has 22 references indexed in Scilit:
- The Impact of Age and Gender on Papillary Thyroid Cancer SurvivalThe Journal of Clinical Endocrinology & Metabolism, 2012
- Prognosis and Prognostic Factors for Distant Metastases and Tumor Mortality in Follicular Thyroid CarcinomaThyroid®, 2011
- Understanding the Relationship Between Age and Thyroid CancerThe Oncologist, 2009
- BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up StudyThe Journal of Clinical Endocrinology & Metabolism, 2008
- Risk Factors Contributing to a Poor Prognosis of Papillary Thyroid Carcinoma: Validity of UICC/AJCC TNM Classification and Stage GroupingWorld Journal of Surgery, 2007
- Is Patient's Age a Prognostic Factor for Follicular Thyroid Carcinoma in the TNM Classification System?Thyroid®, 2005
- Age of Patients with Papillary Thyroid Carcinoma: Is It a Key Factor in the Development of Variants?Gerontology, 2005
- Prognostic significance of the age factor in the thyroid cancer: Statistical analysisJournal of Surgical Oncology, 2004
- Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 PatientsThe Journal of Clinical Endocrinology & Metabolism, 1997
- Prognostic factors for thyroid carcinomaCancer, 1997